Literature DB >> 8034201

Transdermal fentanyl disposition in elderly subjects.

M T Holdsworth1, W B Forman, T A Killilea, K M Nystrom, R Paul, S C Brand, R Reynolds.   

Abstract

The pharmacokinetic characteristics of a 20-cm2 fentanyl 24-hour transdermal patch were compared between 10 healthy elderly subjects 67-87 years and 6 young subjects 19-27 years. All 10 elderly subjects required patch removal prior to 24 h due to adverse effects versus none of the young subjects. The mean patch duration (PD) in elderly subjects was 11.7 +/- 4.9 h, yielding a mean area under the curve from 0 to 60 h (AUC0-60) of 20.4 +/- 10.3 ng h/ml versus a mean AUC0-60 of 21.0 +/- 10.4 ng h/ml in young subjects. Correcting AUC0-60 for PD (AUC0-60/PD) gave a mean value of 2.05 +/- 1.10 ng/ml for elderly subjects, which was significantly greater than the AUC0-60/PD of 0.88 +/- 0.44 ng/ml in young subjects (p = 0.034, Student's t test). The higher serum concentrations reflect increased absorption and/or decreased clearance in the elderly.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034201     DOI: 10.1159/000213572

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  10 in total

1.  Comment on "Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?".

Authors:  Olfat Zekry; Charles A Inderjeeth
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

Review 2.  Pain in nursing home residents: management strategies.

Authors:  D K Weiner; J T Hanlon
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 4.  Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids.

Authors:  Annette L van Ojik; Paul A F Jansen; Jacobus R B J Brouwers; Eric N van Roon
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

Review 5.  Management of opioid analgesic overdose.

Authors:  Edward W Boyer
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

Review 6.  A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.

Authors:  Evelien J M Kuip; Maarten L Zandvliet; Stijn L W Koolen; Ron H J Mathijssen; Carin C D van der Rijt
Journal:  Br J Clin Pharmacol       Date:  2016-10-29       Impact factor: 4.335

Review 7.  Pharmacological treatments for persistent non-malignant pain in older persons.

Authors:  Thorsten Nikolaus; Andrej Zeyfang
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

8.  Formulations of fentanyl for the management of pain.

Authors:  Sina Grape; Stephan A Schug; Stefan Lauer; Barbara S Schug
Journal:  Drugs       Date:  2010       Impact factor: 9.546

9.  The use of opioids at the end of life: the knowledge level of Dutch physicians as a potential barrier to effective pain management.

Authors:  Mette L Rurup; Christiaan A Rhodius; Sander D Borgsteede; Manon Sa Boddaert; Astrid Gm Keijser; H Roeline W Pasman; Bregje D Onwuteaka-Philipsen
Journal:  BMC Palliat Care       Date:  2010-11-12       Impact factor: 3.234

10.  Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl.

Authors:  Natalie Moryl; Ali Bokhari; Yvona Griffo; Rachel Hadler; Lauren Koranteng; Alexandra Filkins; Tianyu Zheng; Susan D Horn; Charles E Inturrisi
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.